世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い



アジア太平洋地域の眼科治療薬とデバイス市場予測 2018-2026年

ASIA PACIFIC OPTHALMOLOGY DRUGS AND DEVICES MARKET FORECAST 2018-2026

 

出版社 出版日電子媒体価格ページ数
Inkwood Research
インクウッドリサーチ
2018年5月 US$ 1,250
シングルユーザライセンス
105p

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

サマリー

この調査レポートはアジア太平洋地域の眼科治療薬とデバイス市場を分析・予測したInkwood Researchの市場調査報告書です。

Description

KEY FINDINGS
The Asia Pacific ophthalmic drugs and devices market holds a high growth potential for the future owing to a large number of factors. These include rising geriatric population, rising investments in healthcare infrastructure and increasing prevalence of ocular diseases like disorders of both the cornea and the retina. By the end of the forecast period of 2018-2026, the market is expected to register a CAGR of 6.22%.
MARKET INSIGHTS
There has been an increasing trend of globalization in clinical research, with the shift of clinical activities to Asia Pacific region. The Asia-Pacific region has extremely assorted healthcare systems; each offering a diverse mix of public/private financing and delivery of medical services. The top five growth sectors in APAC include medical tourism, private medical insurance, and speciality hospitals. The China ophthalmic drugs and devices market captured the highest market share in 2017. Major factors which are driving the ophthalmic drug market in China include the rising geriatric population, increasing strategic moves such as investment, collaboration, and acquisition by key market players in the country, increasing prevalence of eye diseases, increasing healthcare expenditure to improve healthcare infrastructure, and the high life expectancy of individuals.
COMPETITIVE INSIGHTS
Market players like Pfizer, Sun Pharmaceuticals Industries Ltd, Santen Pharmaceutical Co Ltd, Carl Zeiss Ag, GlaxoSmithKline, Novartis International Ag, Valent Pharmaceuticals International Inc, Johnson & Johnson Inc, Allergan Inc, Roche Holding Ag, Bayer, and Ziemer Group Holding Ag are competing in this market.



目次

目次はEメールでお送りいたします。データリソースまでお申し付けください。

 

COPYRIGHT(C) 2011-2019 DATA RESOURCES, Inc. ALL RIGHTS RESERVED.